ASP8374

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ASP8374, covering 2024-11-13 to 2025-10-22. Get the full timeline:

Most recent: Clinical Trial Update: ASP8374 + Cemiplimab in Recurrent Glioma [Phase 1]